Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ali Murat

Showing results (231-240 of 263) with videos related to

Pageof 27
Sort By:
Medicina (Kaunas, Lithuania)|November 27, 2025
Correction: Kalkan et al. Efficacy of Immunotherapy Versus Chemotherapy in Advanced Pleural Mesothelioma: A Turkish Oncology Group (TOG) Study. <i>Medicina</i> 2025, <i>61</i>, 638Ziya Kalkan, Senar Ebinc, Murat Arcagok, et al.
Discover Oncology|May 8, 2026
Real-world outcomes of trifluridine/tipiracil with or without bevacizumab in refractory metastatic colorectal cancer: a multicenter cohort study from TurkeySelami Bayram, Bahadir Koylu, Maral Martin Mildanoglu, et al.
Journal of Cancer Research and Clinical Oncology|May 15, 2023
The effect of concomitant proton pump inhibitor use on survival outcomes of Nivolumab-treated renal cell carcinoma patients: a multicenter studyMuzaffer Uğraklı, Mehmet Zahid Koçak, Gülhan Dinç, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|April 26, 2014
Multicenter epidemiologic study on hepatocellular carcinoma in TurkeyAlper Can, Erkan Dogan, Ibrahim Vedat Bayoglu, et al.
Cancer Chemotherapy and Pharmacology|July 27, 2021
Cetuximab-induced rash is associated with overall survival in patients with recurrent/metastatic squamous cell carcinoma of head and neckSema Sezgin Göksu, Ali Murat Tatlı, Çağlayan Geredeli, et al.
Future Oncology (London, England)|February 26, 2021
Efficacy and tolerability of current treatments for hormone-refractory prostate cancer patients with visceral metastasesZeynep Oruç, M Ali Kaplan, Mustafa Karaağaç, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|May 27, 2015
Prognostic factors in clinical stage T4N2 locally advanced non-small cell lung cancerDeniz Arslan, Deniz Tural, Timur Koca, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|October 24, 2025
Failure patterns and the influence of the TNM staging systems on prognosis in limited disease small cell lung Cancer (SCLC): the Turkish Oncology Group (TOG) studyŞefika Arzu Ergen, Fazilet Öner Dinçbaş, Evrim Metcalfe, et al.
International Orthopaedics|December 13, 2012
Review of Van earthquakes form an orthopaedic perspective: a multicentre retrospective studySavas Guner, Sukriye Ilkay Guner, Yasemin Isik, et al.
Cancers|November 27, 2024
Sequential Use of Sorafenib and Regorafenib in Hepatocellular Cancer Recurrence After Liver Transplantation: Treatment Strategies and OutcomesMehmet Fatih Ozbay, Hakan Harputluoglu, Mustafa Karaca, et al.
Pageof 27

Showing results (231-240 of 263) with videos related to

Sort By:
Pageof 27
Medicina (Kaunas, Lithuania)|November 27, 2025
Correction: Kalkan et al. Efficacy of Immunotherapy Versus Chemotherapy in Advanced Pleural Mesothelioma: A Turkish Oncology Group (TOG) Study. <i>Medicina</i> 2025, <i>61</i>, 638Ziya Kalkan, Senar Ebinc, Murat Arcagok, et al.
Discover Oncology|May 8, 2026
Real-world outcomes of trifluridine/tipiracil with or without bevacizumab in refractory metastatic colorectal cancer: a multicenter cohort study from TurkeySelami Bayram, Bahadir Koylu, Maral Martin Mildanoglu, et al.
Journal of Cancer Research and Clinical Oncology|May 15, 2023
The effect of concomitant proton pump inhibitor use on survival outcomes of Nivolumab-treated renal cell carcinoma patients: a multicenter studyMuzaffer Uğraklı, Mehmet Zahid Koçak, Gülhan Dinç, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|April 26, 2014
Multicenter epidemiologic study on hepatocellular carcinoma in TurkeyAlper Can, Erkan Dogan, Ibrahim Vedat Bayoglu, et al.
Cancer Chemotherapy and Pharmacology|July 27, 2021
Cetuximab-induced rash is associated with overall survival in patients with recurrent/metastatic squamous cell carcinoma of head and neckSema Sezgin Göksu, Ali Murat Tatlı, Çağlayan Geredeli, et al.
Future Oncology (London, England)|February 26, 2021
Efficacy and tolerability of current treatments for hormone-refractory prostate cancer patients with visceral metastasesZeynep Oruç, M Ali Kaplan, Mustafa Karaağaç, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|May 27, 2015
Prognostic factors in clinical stage T4N2 locally advanced non-small cell lung cancerDeniz Arslan, Deniz Tural, Timur Koca, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|October 24, 2025
Failure patterns and the influence of the TNM staging systems on prognosis in limited disease small cell lung Cancer (SCLC): the Turkish Oncology Group (TOG) studyŞefika Arzu Ergen, Fazilet Öner Dinçbaş, Evrim Metcalfe, et al.
International Orthopaedics|December 13, 2012
Review of Van earthquakes form an orthopaedic perspective: a multicentre retrospective studySavas Guner, Sukriye Ilkay Guner, Yasemin Isik, et al.
Cancers|November 27, 2024
Sequential Use of Sorafenib and Regorafenib in Hepatocellular Cancer Recurrence After Liver Transplantation: Treatment Strategies and OutcomesMehmet Fatih Ozbay, Hakan Harputluoglu, Mustafa Karaca, et al.
Pageof 27